Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor beta joining 1-6 (TRBJ1-6) is a gene segment within the T cell receptor (TCR) beta locus, specifically one of the joining regions (J segments) that participate in the V(D)J recombination process essential for generating the diversity of the T cell receptor repertoire in human T lymphocytes[1][2][4][6]. This joining segment is not a standalone receptor or protein product but forms part of the coding sequence for the T cell receptor beta chain, which is critical for antigen recognition as part of the adaptive immune response[2][4][5]. The gene is located within the TRB locus on chromosome 7q34 and is predicted to be involved in the adaptive immune response as it is incorporated into the mature TCR expressed on the surface of T cells after proper recombination events[4][6]. While absolutely essential for the creation of functional TCR diversity, TRBJ1-6 is not itself a drug target or a receptor suitable for direct therapeutic targeting, but rather an essential germline gene segment necessary for tumor recognition, infection response, and immune homeostasis[2][4][6]. Changes or deletions in this and other J segments can affect repertoire diversity, but there are no direct associations with specific drugs, mechanisms of action, or biomarker applications for TRBJ1-6 individually.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor beta joining 1-6 (TRBJ1-6).